Based on the critical roles of LCs in skin immunity and diseases, our findings may help to develop novel therapeutics that target the TGFβ1/Smad4 pathway in LC-related skin diseases. The gene discussed is TGFB1; the disease is laryngotracheoesophageal cleft.